These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 25055060

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Glycoprotein IIB/IIIA inhibitor to reduce postpercutaneous coronary intervention myonecrosis and improve coronary flow in diabetics: the 'OPTIMIZE-IT' pilot randomized study.
    Talarico GP, Brancati M, Burzotta F, Porto I, Trani C, De Vita M, Todaro D, Giammarinaro M, Leone AM, Niccoli G, Andreotti F, Mazzari MA, Schiavoni G, Crea F.
    J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):245-51. PubMed ID: 19262211
    [Abstract] [Full Text] [Related]

  • 43. β-blocker use before elective percutaneous coronary intervention as a risk factor for periprocedural myocardial injury incidence in male patients below 75 years old: a single-center retrospective study.
    Wang M, Lv Q, Wang Y, Wang Y, Lin M, Zhao L, Fu G, Zhang W.
    Ann Palliat Med; 2021 May; 10(5):5055-5068. PubMed ID: 34044554
    [Abstract] [Full Text] [Related]

  • 44. Periprocedural myocardial infarction is associated with increased mortality in patients with coronary artery bifurcation lesions after implantation of a drug-eluting stent.
    Chen SL, Zhang JJ, Ye F, Tian NL, Sheiban I, Jepson N, Paiboon C, Sansoto T, Kwan TW, Wen SY, Wang HC, Jiang TM, Wang Y, Chen LL, Qiu CG, Zhang YJ, Chen MX, De Maria A.
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():696-705. PubMed ID: 25631678
    [Abstract] [Full Text] [Related]

  • 45. Periprocedural myocardial damage during percutaneous coronary intervention: a point-of-care platelet testing and intravascular ultrasound/virtual histology study.
    Michalak M, Huczek Z, Filipiak KJ, Roik MF, Kochman J, Opolski G.
    Kardiol Pol; 2013 Mar; 71(4):325-33. PubMed ID: 23788337
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels predict percutaneous coronary intervention-related periprocedural myocardial infarction in stable patients undergoing elective native single-vessel PCI.
    Balin M, Celik A, Kobat MA, Baydas A.
    J Thromb Thrombolysis; 2012 Nov; 34(4):483-90. PubMed ID: 22797935
    [Abstract] [Full Text] [Related]

  • 48. Incidence, predicting factors, and clinical outcomes of periprocedural myocardial infarction after percutaneous coronary intervention for chronic total occlusion in the era of new-generation drug-eluting stents.
    Kim JH, Kim BK, Kim S, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y.
    Catheter Cardiovasc Interv; 2018 Sep 01; 92(3):477-485. PubMed ID: 29266736
    [Abstract] [Full Text] [Related]

  • 49. Correlates and outcomes related to periprocedural myocardial injury during percutaneous coronary intervention for chronic total occlusion: Results from a prospective, single center PCI registry.
    Zhang Q, Hu J, Yang ZK, Ding FH, Zhang JS, Du R, Zhu TQ, Shen WF, Kirtane AJ, Zhang RY.
    Catheter Cardiovasc Interv; 2016 Mar 01; 87 Suppl 1():616-23. PubMed ID: 26864270
    [Abstract] [Full Text] [Related]

  • 50. The different mechanisms of periprocedural myocardial infarction and their impact on in-hospital outcome.
    Muschart X, Slimani A, Jamart J, Chenu P, Dangoisse V, Gabriel L, Guédès A, Marchandise B, Schröder E.
    J Invasive Cardiol; 2012 Dec 01; 24(12):655-60. PubMed ID: 23220981
    [Abstract] [Full Text] [Related]

  • 51. Outcomes Among Diabetic Patients Undergoing Percutaneous Coronary Intervention With Contemporary Drug-Eluting Stents: Analysis From the BIONICS Randomized Trial.
    Konigstein M, Ben-Yehuda O, Smits PC, Love MP, Banai S, Perlman GY, Golomb M, Ozan MO, Liu M, Leon MB, Stone GW, Kandzari DE.
    JACC Cardiovasc Interv; 2018 Dec 24; 11(24):2467-2476. PubMed ID: 30573057
    [Abstract] [Full Text] [Related]

  • 52. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
    Legrand V, Cuisset T, Chenu P, Vrolix M, Martinez C, Dens J, Gach O, Boland J, Claeys MJ, Magne J, Barbato E, Wijns W.
    EuroIntervention; 2014 Jun 24; 10(2):204-11. PubMed ID: 24952058
    [Abstract] [Full Text] [Related]

  • 53. Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials.
    Mehran R, Pocock S, Nikolsky E, Dangas GD, Clayton T, Claessen BE, Caixeta A, Feit F, Manoukian SV, White H, Bertrand M, Ohman EM, Parise H, Lansky AJ, Lincoff AM, Stone GW.
    JACC Cardiovasc Interv; 2011 Jun 24; 4(6):654-64. PubMed ID: 21700252
    [Abstract] [Full Text] [Related]

  • 54. Coronary artery calcium score in predicting periprocedural myocardial infarction in patients undergoing an elective percutaneous coronary intervention.
    Kang MG, Kang Y, Jang HG, Kim K, Koh JS, Park JR, Hwang SJ, Hwang JY, Bae JS, Ahn JH, Jang JY, Park Y, Jeong YH, Kwak CH, Park HW.
    Coron Artery Dis; 2018 Nov 24; 29(7):589-596. PubMed ID: 29965838
    [Abstract] [Full Text] [Related]

  • 55. Correlation of platelet reactivity and C-reactive protein levels to occurrence of peri-procedural myocardial infarction in patients undergoing percutaneous coronary intervention (from the ARMYDA-CRP study).
    Patti G, Mangiacapra F, Ricottini E, Cannatà A, Cavallari I, Vizzi V, D'Ambrosio A, Dicuonzo G, Di Sciascio G.
    Am J Cardiol; 2013 Jun 15; 111(12):1739-44. PubMed ID: 23538022
    [Abstract] [Full Text] [Related]

  • 56. Predictive value of baseline C-reactive protein for periprocedural myocardial infraction of higher risk stratifications: A retrospective cohort clinical study.
    Yao M, Zhao L, Wu L, Zhang W, Luan Y, Song J, Fu G, Zhu J.
    Anatol J Cardiol; 2018 Dec 15; 20(6):310-317. PubMed ID: 30297597
    [Abstract] [Full Text] [Related]

  • 57. Coronary artery bypass grafting or percutaneous revascularization in acute myocardial infarction?
    Perrier S, Kindo M, Gerelli S, Mazzucotelli JP.
    Interact Cardiovasc Thorac Surg; 2013 Dec 15; 17(6):1015-9. PubMed ID: 23962854
    [Abstract] [Full Text] [Related]

  • 58. Effects of polyunsaturated fatty acids on periprocedural myocardial infarction after elective percutaneous coronary intervention.
    Suzuki A, Ando H, Takashima H, Kumagai S, Kurita A, Waseda K, Suzuki Y, Mizuno T, Harada K, Uetani T, Takahashi H, Yoshikawa D, Ishii H, Murohara T, Amano T.
    EuroIntervention; 2014 Nov 15; 10(7):792-8. PubMed ID: 25415148
    [Abstract] [Full Text] [Related]

  • 59. Baseline inflammation is not predictive of periprocedural troponin elevation after elective percutaneous coronary intervention.
    Gach O, Louis O, Chapelle JP, Vanbelle S, Pierard LA, Legrand V.
    Heart Vessels; 2009 Jul 15; 24(4):267-70. PubMed ID: 19626398
    [Abstract] [Full Text] [Related]

  • 60. Association of serum laboratory parameters with periprocedural myocardial infarction after a primary percutaneous coronary intervention.
    Deng Q, Hou J, Deng X, Zhong Z.
    Perfusion; 2023 Mar 15; 38(2):393-400. PubMed ID: 35038275
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.